Le Lézard
Classified in: Science and technology
Subjects: PER, EXE

General John M. Murray (Ret.), Former Commander of Army Futures Command, Joins Vita Inclinata as Strategic Advisor to the Board of Directors


Gen. Murray to Help Vita Disrupt Traditional Defense Acquisitions for New and Emerging Technologies and Products

WASHINGTON, May 10, 2022 /PRNewswire/ -- Vita Inclinata, developer and producer of precision aerospace and industrial stabilization devices, today announced Gen. John M Murray (Ret.) as Vita Inclinata's ("Vita") Strategic Advisor to the Board of Directors. Gen. Murray joins a prestigious team of board members, including recently announced Lt. Gen. Paul Ostrowski (Ret.) and others, to leverage his deep expertise and understanding of U.S. Army acquisitions and defense innovation ecosystems to guide the company's board of directors and leadership.      

General Murray retired from the U.S. Army as a four-star general overseeing U.S. Army Futures Command from 2018 to December 2021. Before the Army Futures Command, General Murray served as the Army Deputy Chief of Staff, G-8, and commanded the 3rd Infantry Division during Operations Enduring Freedom and Resolute Support.

"I firmly believe that the technology Vita is delivering to our warfighters will make MEDEVAC operations safer and ultimately save lives," Murray said. "I'm committed to helping Vita disrupt traditional U.S. Government contract development by identifying solutions to 'cross the valley of death.' For too many years, the U.S. Army has relied entirely on the innovation of the traditional defense industry and has not taken advantage of small company break-through technologies such as the Vita Rescue System."

Vita Inclinata is well known within the defense innovation ecosystem, having received millions of dollars from the USAF's innovation vehicle AFWERX. The company also has received awards such as the grand prize winner of the U.S. Army's innovation program known as xTechSearch.

"General Murray is a perfect collaborator and mentor for Vita as the company works with Congress and the Defense Department to define and develop the defense innovation ecosystem," says Caleb Carr, CEO of Vita Inclinata.

About Vita Inclinata

A friend's death during a rescue operation?with a helicopter close but unable to stabilize due to weather and terrain?was the genesis of Vita Inclinata. Founded in 2015 as a way to solve a real problem, Vita today controls chaotic swinging and spin and adds safety and precision for rotor-wing and fixed-wing aircraft and cranes. With the mission of "Bring them home, every time," Vita's technology changes the narrative while saving lives, time, and money across industries, including search and rescue, military, firefighting, public safety, construction, wind energy, and oil and gas. The company is headquartered in Broomfield, Colorado, with offices in Washington, DC, and Huntsville, Alabama. For more information, please visit www.vitatech.co.

For more information or to schedule an interview, please contact:

Betsey Rogers
BridgeView Marketing
603-821-0809
[email protected]

SOURCE Vita Inclinata


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: